Bluefish Pharma AB
Closing information (x1000 DKK)
| Closing information | 2023/04 | 2022/04 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
0
|
0
|
0 |
| EBITDA |
0
|
0
|
0 |
| Total assets |
70
|
77
|
77 |
| Current assets |
70
|
77
|
77 |
| Current liabilities |
0
|
0
|
0 |
| Equity capital |
70
|
77
|
77 |
| - share capital |
33
|
36
|
36 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/04 | 2022/04 | 2021/12 |
| Solvency |
100%
|
100%
|
100% |
| Turnover per employee | |||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
0%
|
0%
|
0% |
| Current ratio | |||
| Return on equity (ROE) |
0%
|
0%
|
0% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/04 | 2022/04 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.